Skip to content

Clinical trials

Phase 3 Neuralgia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 3 Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20042
20057
20068
20071
20083
20092
20104
20115
20124
20132
20141
20151
20162
20173
20182
20194
20201
20211
20222
20238
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status15
Terminated6
Recruiting5
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
Apurano Pharmaceuticals GmbH4
NeurogesX4
University of Sao Paulo4
Grünenthal GmbH3
Assistance Publique - Hôpitaux de Paris2
BioDelivery Sciences International2
Pfizer2
University Hospital, Clermont-Ferrand2
Advanced Magnetic Research Institute International1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia73
Pain22
Chronic Pain11
Diabetic Neuropathies11
Peripheral Nervous System Diseases8
Postoperative Pain7
Agnosia6
Spinal Cord Injuries6
Low Back Pain4
Marijuana Abuse4

Trials

Showing 51 to 73 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.